Location History:
- San Francisco, CA (US) (2012)
- Redwood City, CA (US) (2019)
- South San Francisco, CA (US) (2018 - 2021)
Company Filing History:
9 out of 3,222 
6 out of 109 
1 out of 6 Years Active: 2012-2025
Title: Inventor Philippe Bergeron: Pioneering Innovations in Sodium Channel Inhibition
Introduction
Philippe Bergeron is a prominent inventor based in South San Francisco, CA, known for his significant contributions to pharmacology and medicinal chemistry. With a total of nine patents to his name, Bergeron's work centers around the development of innovative compounds aimed at treating sodium channel-mediated diseases, particularly pain.
Latest Patents
Bergeron’s most recent patents include "Pyridine-sulfonamide derivatives as sodium channel inhibitors," which details a compound formula that exhibits sodium channel blocking activity. These compounds are designed to provide therapeutic solutions for conditions associated with pain. Another key patent is related to "Therapeutic compounds and methods of use thereof," which covers a general compound formula and its applications in medical treatments. Both inventions focus on the formulation and application of compounds to create effective treatments for ailments linked to sodium channel dysfunction.
Career Highlights
Throughout his career, Bergeron has worked with notable companies in the biopharmaceutical industry, including Genentech, Inc. and Xenon Pharmaceuticals, Inc. His tenure at these organizations has been instrumental in pushing forward the boundaries of research in drug development, directly contributing to the pipeline of potential medications that target sodium channels.
Collaborations
Philippe Bergeron has collaborated with various professionals in his field, including notable colleagues such as Sultan Chowdhury and Christoph Martin Dehnhardt. These collaborations have enriched his research, promoting an exchange of ideas and fostering innovative approaches to problem-solving in the realm of pharmacology.
Conclusion
Philippe Bergeron's dedication to innovation in sodium channel inhibition highlights his valuable role in the field of medicinal chemistry. With multiple patents showcasing his inventive prowess, Bergeron continues to be a significant force in developing therapeutic solutions that can alleviate pain and improve the quality of life for individuals suffering from sodium channel-mediated diseases.